BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group

Reuters

Jun 04, 2025

** Shares of Rua Bioscience RUA.NZ rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain

** Medical cannabis firm reaches settlement with Australian peer Cann Group CAN.AX following legal proceedings initiated by Rua in February 2024

** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia

** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade

** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia

** More than 129,000 shares change hands, 1.9 times its 30-day avg volume

** Rua down 3.5% YTD, including current session's moves

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2540855550"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540855550\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2540855550?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-04 08:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540855550","market":"nz","top_or_hot":-1,"title":"BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group</title></head><body><p>** Shares of Rua Bioscience <span>RUA.NZ</span> rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain</p><p>** Medical cannabis firm <span>reaches</span> settlement with Australian peer Cann Group <span>CAN.AX</span> following legal proceedings initiated by Rua in February 2024</p><p>** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia</p><p>** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade</p><p>** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia</p><p>** More than 129,000 shares change hands, 1.9 times its 30-day avg volume</p><p>** Rua down 3.5% YTD, including current session's moves</p><p>(Reporting by Nikita Maria Jino in Bengaluru)</p><p>((Nikita.Jino@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-04 08:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group</title></head><body><p>** Shares of Rua Bioscience <span>RUA.NZ</span> rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain</p><p>** Medical cannabis firm <span>reaches</span> settlement with Australian peer Cann Group <span>CAN.AX</span> following legal proceedings initiated by Rua in February 2024</p><p>** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia</p><p>** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade</p><p>** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia</p><p>** More than 129,000 shares change hands, 1.9 times its 30-day avg volume</p><p>** Rua down 3.5% YTD, including current session's moves</p><p>(Reporting by Nikita Maria Jino in Bengaluru)</p><p>((Nikita.Jino@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL6N3S700S:1","article_id":"2540855550","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540855550","pubTimestamp":1748996454,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-New Zealand's Rua Bioscience surges on legal resolutionwith Australia's Cann Group** Shares of Rua Bioscience RUA.NZ rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain** Medical cannabis firm reaches settlement with Australian peer Cann Group CAN.AX following legal proceedings initiated by Rua in February 2024** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia** More than 129,000 shares change hands, 1.9 times its 30-day avg volume** Rua down 3.5% YTD, including current session's moves","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","CAN.AU":"CANN GROUP LTD","BK7502":"大麻概念","BK7508":"医药生物股"},"translate_title":"BUZZ-新西兰Rua Bioscience因与澳大利亚Cann Group的法律解决而股价飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAN.AU":0.9},"content_text":"BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group** Shares of Rua Bioscience RUA.NZ rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain** Medical cannabis firm reaches settlement with Australian peer Cann Group CAN.AX following legal proceedings initiated by Rua in February 2024** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia** More than 129,000 shares change hands, 1.9 times its 30-day avg volume** Rua down 3.5% YTD, including current session's moves(Reporting by Nikita Maria Jino in Bengaluru)((Nikita.Jino@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}